Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Conor A. Ruzycki, Derek Montoya, Hammad Irshad, Jason Cox, Yue Zhou, Jacob D. McDonald & Philip J. Kuehl. (2023) Inhalation delivery of nucleic acid gene therapies in preclinical drug development. Expert Opinion on Drug Delivery 20:8, pages 1097-1113.
Read now
Read now
Simone P. Carneiro, Antonietta Greco, Enrica Chiesa, Ida Genta & Olivia M. Merkel. (2023) Shaping the future from the small scale: dry powder inhalation of CRISPR-Cas9 lipid nanoparticles for the treatment of lung diseases. Expert Opinion on Drug Delivery 20:4, pages 471-487.
Read now
Read now
Articles from other publishers (18)
Maryam Tavakolizadeh, Monireh Atarod, Seyyed Javad Seyyed Tabaei, Soheil Sojdeh, Ehsan Nazarzadeh Zare, Mohammad Rabiee & Navid Rabiee. (2023) Green modified-UiO-66/MXene sandwich composites for gene-chemotherapy synergistic cancer suppression: Co-delivery of doxorubicin and pCRISPR. Alexandria Engineering Journal 80, pages 144-154.
Crossref
Crossref
Jiaojiao Zhang, Zixuan Wang, Jiwei Min, Xuelin Zhang, Rongxin Su, Yuefei Wang & Wei Qi. (2023) Self-Assembly of Peptide–Lipid Nanoparticles for the Efficient Delivery of Nucleic Acids. Langmuir 39:21, pages 7484-7494.
Crossref
Crossref
Hezhi Wang, Lu Qin, Xin Zhang, Jian Guan & Shirui Mao. (2022) Mechanisms and challenges of nanocarriers as non-viral vectors of therapeutic genes for enhanced pulmonary delivery. Journal of Controlled Release 352, pages 970-993.
Crossref
Crossref
Xiaochen Gong, Yuan Gao, Jianhong Shu, Chunjing Zhang & Kai Zhao. (2022) Chitosan-Based Nanomaterial as Immune Adjuvant and Delivery Carrier for Vaccines. Vaccines 10:11, pages 1906.
Crossref
Crossref
Shipeng Chen, Lian Guan, Xu Zhao, Jing Yang, Longqing Chen, Mengmeng Guo, Juanjuan Zhao, Chao Chen, Ya Zhou, Yong Han & Lin Xu. (2022) Optimized thyroid transcription factor-1 core promoter-driven microRNA-7 expression effectively inhibits the growth of human non-small-cell lung cancer cells优化的TTF-1核心启动子驱动miRNA-7表达有效抑制人非小细胞肺癌细胞的生长. Journal of Zhejiang University-SCIENCE B 23:11, pages 915-930.
Crossref
Crossref
Teng Huang, Jia Gao, Long Cai, Hao Xie, Yuhan Wang, Yi Wang & Qing Zhou. (2022) Treating Pulmonary Fibrosis with Non-Viral Gene Therapy: From Bench to Bedside. Pharmaceutics 14:4, pages 813.
Crossref
Crossref
Sabya Sachi Das, Sandeep Kumar Singh, PRP Verma, Niraj Kumar Jha, Piyush Kumar Gupta & Kamal Dua. (2022) Mitigating inflammation using advanced drug delivery by targeting TNF-α in lung diseases. Future Medicinal Chemistry 14:2, pages 57-60.
Crossref
Crossref
Chenbing Wu, Weiwei Yan, Rou Chen, Yang Liu & Guozhan Li. (2022) Numerical study on targeted delivery of magnetic drug particles in realistic human lung. Powder Technology 397, pages 116984.
Crossref
Crossref
Małgorzata Kubczak, Sylwia Michlewska, Maria Bryszewska, Achim Aigner & Maksim Ionov. (2021) Nanoparticles for local delivery of siRNA in lung therapy. Advanced Drug Delivery Reviews 179, pages 114038.
Crossref
Crossref
Li Ding, Ashlee D. Brunaugh, Sven Stegemann, Scott V. Jermain, Matthew J. Herpin, Justin Kalafat & Hugh D. C. Smyth. (2021) A Quality by Design Framework for Capsule-Based Dry Powder Inhalers. Pharmaceutics 13:8, pages 1213.
Crossref
Crossref
Myriam Sainz-Ramos, Idoia Gallego, Ilia Villate-Beitia, Jon Zarate, Iván Maldonado, Gustavo Puras & Jose Luis Pedraz. (2021) How Far Are Non-Viral Vectors to Come of Age and Reach Clinical Translation in Gene Therapy?. International Journal of Molecular Sciences 22:14, pages 7545.
Crossref
Crossref
K. Sreedurgalakshmi, R. Srikar & Reena Rajkumari. (2020) CRISPR-Cas deployment in non-small cell lung cancer for target screening, validations, and discoveries. Cancer Gene Therapy 28:6, pages 566-580.
Crossref
Crossref
Yongtao Wang, Yingjun Yang, Xinlong Wang, Naoki Kawazoe, Yingnan Yang & Guoping Chen. (2021) The varied influences of cell adhesion and spreading on gene transfection of mesenchymal stem cells on a micropatterned substrate. Acta Biomaterialia 125, pages 100-111.
Crossref
Crossref
Michael Y.T. Chow, Rachel Yoon Kyung Chang & Hak-Kim Chan. (2021) Inhalation delivery technology for genome-editing of respiratory diseases. Advanced Drug Delivery Reviews 168, pages 217-228.
Crossref
Crossref
The-Thien Tran, Nur Amalina, Wean Sin Cheow & Kunn Hadinoto. (2020) Effects of storage on the stability and aerosolization efficiency of dry powder inhaler formulation of plasmid DNA-Chitosan nanoparticles. Journal of Drug Delivery Science and Technology 59, pages 101866.
Crossref
Crossref
Reza Mohammadinejad, Ali Dehshahri, Vijay Sagar Madamsetty, Masoumeh Zahmatkeshan, Shima Tavakol, Pooyan Makvandi, Danial Khorsandi, Abbas Pardakhty, Milad Ashrafizadeh, Elham Ghasemipour Afshar & Ali Zarrabi. (2020) In vivo gene delivery mediated by non-viral vectors for cancer therapy. Journal of Controlled Release 325, pages 249-275.
Crossref
Crossref
Tiffany M. Carlaw, Lin-Hua ZhangColin J.D. Ross. (2020) CRISPR/Cas9 Editing: Sparking Discussion on Safety in Light of the Need for New Therapeutics. Human Gene Therapy 31:15-16, pages 794-807.
Crossref
Crossref
Hua Alexander Han, Jeremy Kah Sheng Pang & Boon-Seng Soh. (2020) Mitigating off-target effects in CRISPR/Cas9-mediated in vivo gene editing. Journal of Molecular Medicine 98:5, pages 615-632.
Crossref
Crossref